Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

DermTech, Inc.

DMTK•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.09
$-0.01(-11.32%)
U.S. Market opens in 13h 38m

DermTech, Inc. (DMTK) Stock Overview

Explore DermTech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.3M
P/E Ratio-0.03
EPS (TTM)$-2.65
ROE-1.06%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

DMTK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DermTech, Inc. (DMTK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 3.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
42.21%
1-Month Change
N/A
3-Month Change
-84.41%
6-Month Change
-92.71%
Year-to-Date (YTD) Change
-94.34%
1-Year Change
-97.12%
3-Year Change
-99.72%
5-Year Change
-99.55%
All-Time (Max) Change
-99.52%

Contact Information

https://www.dermtech.com
858 450 4222
11099 North Torrey Pines Road, La Jolla, CA, 92037

Company Facts

2,060 Employees
IPO DateAug 10, 2017
CountryUS

Frequently Asked Questions